Assenagon Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,409
| Closed | -$329K | – | 1290 |
|
|
2024
Q3 | $329K | Sell |
7,409
-127,571
| -95% | -$5.67M | ﹤0.01% | 1246 |
|
|
2024
Q2 | $5.82M | Sell |
134,980
-319,821
| -70% | -$13.8M | 0.01% | 565 |
|
|
2024
Q1 | $13.3M | Buy |
454,801
+404,297
| +801% | +$11.8M | 0.03% | 341 |
|
|
2023
Q4 | $1.12M | Buy |
50,504
+41,768
| +478% | +$930K | ﹤0.01% | 1036 |
|
|
2023
Q3 | $216K | Hold |
8,736
| – | – | ﹤0.01% | 1290 |
|
|
2023
Q2 | $247K | Sell |
8,736
-89,847
| -91% | -$2.54M | ﹤0.01% | 1214 |
|
|
2023
Q1 | $2.26M | Sell |
98,583
-13,905
| -12% | -$319K | 0.01% | 771 |
|
|
2022
Q4 | $3.16M | Buy |
112,488
+18,839
| +20% | +$529K | 0.01% | 630 |
|
|
2022
Q3 | $2.65M | Sell |
93,649
-15,653
| -14% | -$443K | 0.01% | 610 |
|
|
2022
Q2 | $2.42M | Buy |
+109,302
| New | +$2.42M | 0.01% | 736 |
|
|
2020
Q3 | – | Sell |
-51,412
| Closed | -$2.75M | – | 1064 |
|
|
2020
Q2 | $2.75M | Buy |
+51,412
| New | +$2.75M | 0.02% | 475 |
|